Skip to content
Biodatica
Start free

Tata Memorial Centre

Mumbai, Maharashtra

OncologyPhase III
Compare Sign in to watch

What changed

Phase III trial registered: Short Versus Long-term Levetiracetam in Brain Tumors

5mo agoTrial registeredFeb 13, 2026Source filing (opens the source filing in a new tab)

Momentum

81no change

Momentum 81 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

497 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Nov 30, 2025

    Diffuse Glioma, Glioblastoma, Adaptive Radiotherapy, Artificial Intelligence · NOT_YET_RECRUITING · sponsor: Tata Memorial Centre · Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

    ClinicalTrials.gov · NCT06492486 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Feb 11, 2025

    Brain Tumors, Medulloblastoma, Glioma, Ependymoma · RECRUITING · sponsor: Tata Memorial Centre · Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

    ClinicalTrials.gov · NCT06779487 (opens the source filing in a new tab)

  3. Trial

    Study registered

    Jan 10, 2025

    Brain Tumor, Oncology · RECRUITING · sponsor: Tata Memorial Centre · Tracing Brain Tumors Through Deep Time

    ClinicalTrials.gov · NCT06381531 (opens the source filing in a new tab)

  4. Trial

    PHASE3 registered

    Jul 4, 2024

    Seizures, Brain Tumors, Antiepileptics, Levetiracetam · RECRUITING · sponsor: Tata Memorial Centre · Short Versus Long-term Levetiracetam in Brain Tumors

    ClinicalTrials.gov · NCT06442748 (opens the source filing in a new tab)

  5. Trial

    Study registered

    Feb 15, 2024

    Glioma · RECRUITING · sponsor: Tata Memorial Centre · Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis

    ClinicalTrials.gov · NCT06036381 (opens the source filing in a new tab)

  6. Trial

    PHASE2 registered

    Nov 13, 2023

    Diffuse Glioma, Radionecrosis of Brain, High Grade Glioma, Glioblastoma Multiforme · RECRUITING · sponsor: Tata Memorial Centre · A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma

    ClinicalTrials.gov · NCT06016452 (opens the source filing in a new tab)

  7. Trial

    Study registered

    Sep 13, 2023

    CNS Tumor · RECRUITING · sponsor: Tata Memorial Centre · Artificial Intelligence in CNS Radiation Oncology

    ClinicalTrials.gov · NCT06036394 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources